Financials data is unavailable for this security.
View more
Year on year Pfizer Inc 's net income fell -3.25% from 8.03bn to 7.77bn despite relatively flat revenues.
| Gross margin | 75.81% |
|---|---|
| Net profit margin | 12.44% |
| Operating margin | 15.43% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in USDView more
In 2024, cash reserves at Pfizer Inc fell by 1.81bn. However, the company earned 12.74bn from its operations for a Cash Flow Margin of 20.03%. In addition the company generated 2.65bn cash from investing, though they paid out 17.14bn more in financing than they received.
| Cash flow per share | 2.44 |
|---|---|
| Price/Cash flow per share | 11.18 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in USDView more
SmartText is unavailable
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in USD
SmartText is unavailable
| Div yield(5 year avg) | 4.30% |
|---|---|
| Div growth rate (5 year) | 2.50% |
| Payout ratio (TTM) | 63.14% |
| EPS growth(5 years) | 2.87 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -3.66 |
More ▼
